Cargando…

T-Natural Killers and Interferon Gamma/Interleukin 4 in Augmentation of Infection in Foot Ulcer in Type 2 Diabetes

BACKGROUND: The link between immune system and type 2 diabetes mellitus (T2DM) pathogenesis attracted attention to demonstrate the role of immune cells and their secreted cytokines in T2DM development and its subsequent foot complications. OBJECTIVE: To investigate the relation between T Natural kil...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammad, Reham, Elmadbouly, Asmaa A, Ahmad, Inass Hassan, Mohammed, Shaymaa A, Farouk, Nehal, Futooh, Zahraa, Alfy, Mohamed Omar, Abozaid, Sarah, Mohamed, Eman F, Kotb, Fatma M, Abdelbadea, Alzahra, Seliem, Nora, Elshafei, Ahmed, Mashaal, Alya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093190/
https://www.ncbi.nlm.nih.gov/pubmed/33958881
http://dx.doi.org/10.2147/DMSO.S305511
_version_ 1783687764686929920
author Hammad, Reham
Elmadbouly, Asmaa A
Ahmad, Inass Hassan
Mohammed, Shaymaa A
Farouk, Nehal
Futooh, Zahraa
Alfy, Mohamed Omar
Abozaid, Sarah
Mohamed, Eman F
Kotb, Fatma M
Abdelbadea, Alzahra
Seliem, Nora
Elshafei, Ahmed
Mashaal, Alya
author_facet Hammad, Reham
Elmadbouly, Asmaa A
Ahmad, Inass Hassan
Mohammed, Shaymaa A
Farouk, Nehal
Futooh, Zahraa
Alfy, Mohamed Omar
Abozaid, Sarah
Mohamed, Eman F
Kotb, Fatma M
Abdelbadea, Alzahra
Seliem, Nora
Elshafei, Ahmed
Mashaal, Alya
author_sort Hammad, Reham
collection PubMed
description BACKGROUND: The link between immune system and type 2 diabetes mellitus (T2DM) pathogenesis attracted attention to demonstrate the role of immune cells and their secreted cytokines in T2DM development and its subsequent foot complications. OBJECTIVE: To investigate the relation between T Natural killer cell (TNK) %, Interleukin 4 (IL4) and Interferon gamma (IFN-γ) and diabetic foot infection (DFI) development in patients with diabetic foot ulcer (DFU). PATIENTS AND METHODS: Ninety patients with diabetes were included in this work, divided as T2DM group (n=30), DFU group (n=30), and DFI group (n=30). TNK% was detected using flow cytometry. Serum IL4 and IFN-γ were measured by ELISA. Diabetes biochemical parameters were also analyzed. RESULTS: Significant decrease was detected in TNK% and IFN-γ in DFI group compared to other 2 groups (P<0.001). Significant decrease was detected in serum levels of IL4 in DFI group compared to T2DM group (P=0.006). IFN-γ/IL4 was significantly decreased in DFI compared to DFU group (P=0.020). There was a significant correlation of TNK% with both IL4 and IFN-γ (r=0.385, P<0.001; r=0.534, P<0.001, respectively). Significant negative correlation of TNK% with HbA1c and LDL was revealed (r=−0.631, P<0.001; and r=−0.261, P=0.013, respectively), while a positive correlation was seen with HDL (r=0.287, P=0.006). A significant negative correlation of IL4 with HbA1c  was found (r=−0.514, P<0.001;. As for IFN-γ, a significant negative correlation with HbA1c and LDL was detected (r=−0.369, P< 0.001; r=−0.229, P=0.030). TNK % and IFN-γ level showed negative correlations with disease duration/year (r=−0.546, P< 0.001; r=−0.338, P=0.001,respectively). CONCLUSION: Decline in TNK frequency has essential role in T2DM pathogenesis and subsequent foot complications. Downregulation of TNK% and IFN-γ level have potential roles in predicting infection of diabetic ulcer and are correlated with disease duration.
format Online
Article
Text
id pubmed-8093190
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-80931902021-05-05 T-Natural Killers and Interferon Gamma/Interleukin 4 in Augmentation of Infection in Foot Ulcer in Type 2 Diabetes Hammad, Reham Elmadbouly, Asmaa A Ahmad, Inass Hassan Mohammed, Shaymaa A Farouk, Nehal Futooh, Zahraa Alfy, Mohamed Omar Abozaid, Sarah Mohamed, Eman F Kotb, Fatma M Abdelbadea, Alzahra Seliem, Nora Elshafei, Ahmed Mashaal, Alya Diabetes Metab Syndr Obes Original Research BACKGROUND: The link between immune system and type 2 diabetes mellitus (T2DM) pathogenesis attracted attention to demonstrate the role of immune cells and their secreted cytokines in T2DM development and its subsequent foot complications. OBJECTIVE: To investigate the relation between T Natural killer cell (TNK) %, Interleukin 4 (IL4) and Interferon gamma (IFN-γ) and diabetic foot infection (DFI) development in patients with diabetic foot ulcer (DFU). PATIENTS AND METHODS: Ninety patients with diabetes were included in this work, divided as T2DM group (n=30), DFU group (n=30), and DFI group (n=30). TNK% was detected using flow cytometry. Serum IL4 and IFN-γ were measured by ELISA. Diabetes biochemical parameters were also analyzed. RESULTS: Significant decrease was detected in TNK% and IFN-γ in DFI group compared to other 2 groups (P<0.001). Significant decrease was detected in serum levels of IL4 in DFI group compared to T2DM group (P=0.006). IFN-γ/IL4 was significantly decreased in DFI compared to DFU group (P=0.020). There was a significant correlation of TNK% with both IL4 and IFN-γ (r=0.385, P<0.001; r=0.534, P<0.001, respectively). Significant negative correlation of TNK% with HbA1c and LDL was revealed (r=−0.631, P<0.001; and r=−0.261, P=0.013, respectively), while a positive correlation was seen with HDL (r=0.287, P=0.006). A significant negative correlation of IL4 with HbA1c  was found (r=−0.514, P<0.001;. As for IFN-γ, a significant negative correlation with HbA1c and LDL was detected (r=−0.369, P< 0.001; r=−0.229, P=0.030). TNK % and IFN-γ level showed negative correlations with disease duration/year (r=−0.546, P< 0.001; r=−0.338, P=0.001,respectively). CONCLUSION: Decline in TNK frequency has essential role in T2DM pathogenesis and subsequent foot complications. Downregulation of TNK% and IFN-γ level have potential roles in predicting infection of diabetic ulcer and are correlated with disease duration. Dove 2021-04-29 /pmc/articles/PMC8093190/ /pubmed/33958881 http://dx.doi.org/10.2147/DMSO.S305511 Text en © 2021 Hammad et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Hammad, Reham
Elmadbouly, Asmaa A
Ahmad, Inass Hassan
Mohammed, Shaymaa A
Farouk, Nehal
Futooh, Zahraa
Alfy, Mohamed Omar
Abozaid, Sarah
Mohamed, Eman F
Kotb, Fatma M
Abdelbadea, Alzahra
Seliem, Nora
Elshafei, Ahmed
Mashaal, Alya
T-Natural Killers and Interferon Gamma/Interleukin 4 in Augmentation of Infection in Foot Ulcer in Type 2 Diabetes
title T-Natural Killers and Interferon Gamma/Interleukin 4 in Augmentation of Infection in Foot Ulcer in Type 2 Diabetes
title_full T-Natural Killers and Interferon Gamma/Interleukin 4 in Augmentation of Infection in Foot Ulcer in Type 2 Diabetes
title_fullStr T-Natural Killers and Interferon Gamma/Interleukin 4 in Augmentation of Infection in Foot Ulcer in Type 2 Diabetes
title_full_unstemmed T-Natural Killers and Interferon Gamma/Interleukin 4 in Augmentation of Infection in Foot Ulcer in Type 2 Diabetes
title_short T-Natural Killers and Interferon Gamma/Interleukin 4 in Augmentation of Infection in Foot Ulcer in Type 2 Diabetes
title_sort t-natural killers and interferon gamma/interleukin 4 in augmentation of infection in foot ulcer in type 2 diabetes
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093190/
https://www.ncbi.nlm.nih.gov/pubmed/33958881
http://dx.doi.org/10.2147/DMSO.S305511
work_keys_str_mv AT hammadreham tnaturalkillersandinterferongammainterleukin4inaugmentationofinfectioninfootulcerintype2diabetes
AT elmadboulyasmaaa tnaturalkillersandinterferongammainterleukin4inaugmentationofinfectioninfootulcerintype2diabetes
AT ahmadinasshassan tnaturalkillersandinterferongammainterleukin4inaugmentationofinfectioninfootulcerintype2diabetes
AT mohammedshaymaaa tnaturalkillersandinterferongammainterleukin4inaugmentationofinfectioninfootulcerintype2diabetes
AT farouknehal tnaturalkillersandinterferongammainterleukin4inaugmentationofinfectioninfootulcerintype2diabetes
AT futoohzahraa tnaturalkillersandinterferongammainterleukin4inaugmentationofinfectioninfootulcerintype2diabetes
AT alfymohamedomar tnaturalkillersandinterferongammainterleukin4inaugmentationofinfectioninfootulcerintype2diabetes
AT abozaidsarah tnaturalkillersandinterferongammainterleukin4inaugmentationofinfectioninfootulcerintype2diabetes
AT mohamedemanf tnaturalkillersandinterferongammainterleukin4inaugmentationofinfectioninfootulcerintype2diabetes
AT kotbfatmam tnaturalkillersandinterferongammainterleukin4inaugmentationofinfectioninfootulcerintype2diabetes
AT abdelbadeaalzahra tnaturalkillersandinterferongammainterleukin4inaugmentationofinfectioninfootulcerintype2diabetes
AT seliemnora tnaturalkillersandinterferongammainterleukin4inaugmentationofinfectioninfootulcerintype2diabetes
AT elshafeiahmed tnaturalkillersandinterferongammainterleukin4inaugmentationofinfectioninfootulcerintype2diabetes
AT mashaalalya tnaturalkillersandinterferongammainterleukin4inaugmentationofinfectioninfootulcerintype2diabetes